PMV Pharmaceuticals, Inc. — All Filings
364 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
3/A
4
4/A
424B3
424B4
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
POSASR
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0001373604-25-000028 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001373604-25-000029 | Feb 14, 2025 | — |
| SCHEDULE 13G | — | 0001214659-25-002314 | Feb 10, 2025 | — |
| S-8 | S-8 | 0001193125-25-014448 | Jan 28, 2025 | — |
| 4 | — | 0001415889-25-001853 | Jan 22, 2025 | Dec 3, 2024 |
| SC 13G | — | 0001373604-24-000110 | Dec 12, 2024 | — |
| EFFECT | — | 9999999995-24-003606 | Nov 27, 2024 | — |
| 424B3 | 424B3 | 0001193125-24-267229 | Nov 27, 2024 | — |
| UPLOAD | — | 0000000000-24-013056 | Nov 25, 2024 | — |
| CORRESP | — | 0001193125-24-265243 | Nov 25, 2024 | — |
| S-3 | S-3 | 0001193125-24-262148 | Nov 20, 2024 | — |
| SC 13G/A | — | 0001172661-24-004898 | Nov 14, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-122817 | Nov 7, 2024 | Sep 30, 2024 |
| 8-K | 8-K | 0000950170-24-122816 | Nov 7, 2024 | — |
| 4 | — | 0001415889-24-024622 | Oct 3, 2024 | Aug 13, 2024 |
| 4 | — | 0001415889-24-024624 | Oct 3, 2024 | Aug 13, 2024 |
| 4 | — | 0001415889-24-024627 | Oct 3, 2024 | Aug 13, 2024 |
| 4 | — | 0001415889-24-023313 | Sep 12, 2024 | Sep 11, 2024 |
| 4 | — | 0001415889-24-023309 | Sep 12, 2024 | Sep 11, 2024 |
| SC TO-I/A | SC TO-I/A | 0001193125-24-200605 | Aug 14, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-093343 | Aug 8, 2024 | Jun 30, 2024 |
| 8-K | 8-K | 0000950170-24-093345 | Aug 8, 2024 | Aug 5, 2024 |
| SC TO-I | SC TO-I | 0001193125-24-179366 | Jul 16, 2024 | — |
| SC 13G/A | — | 0001086364-24-008191 | Jul 8, 2024 | — |
| 4 | — | 0001415889-24-016238 | Jun 10, 2024 | Jun 6, 2024 |
| 4 | — | 0001415889-24-016199 | Jun 10, 2024 | Jun 6, 2024 |
| 4 | — | 0001415889-24-016236 | Jun 10, 2024 | Jun 6, 2024 |
| 4 | — | 0001415889-24-016202 | Jun 10, 2024 | Jun 6, 2024 |
| 4 | — | 0001415889-24-016208 | Jun 10, 2024 | Jun 6, 2024 |
| 4 | — | 0001415889-24-016214 | Jun 10, 2024 | Jun 6, 2024 |
| 8-K | 8-K | 0001193125-24-156745 | Jun 7, 2024 | Jun 6, 2024 |
| 8-K | 8-K | 0000950170-24-056294 | May 9, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-056295 | May 9, 2024 | Mar 31, 2024 |
| DEFA14A | DEFA14A | 0001140361-24-021597 | Apr 24, 2024 | — |
| ARS | ARS | 0001140361-24-021598 | Apr 24, 2024 | Dec 31, 2023 |
| DEF 14A | DEF 14A | 0001140361-24-021596 | Apr 24, 2024 | Jun 6, 2024 |
| 10-K | 10-K | 0000950170-24-023062 | Feb 29, 2024 | Dec 31, 2023 |
| 8-K | 8-K | 0000950170-24-023058 | Feb 29, 2024 | — |
| SC 13G/A | PMV PHARMACEUTICALS, INC. | 0000902664-24-001604 | Feb 14, 2024 | — |
| SC 13G | — | 0001172661-24-001360 | Feb 14, 2024 | — |
| SC 13G/A | — | 0000895345-24-000060 | Feb 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-023955 | Feb 14, 2024 | — |
| SC 13G/A | PMV PHARMACEUTICALS, INC. | 0000902664-24-001575 | Feb 14, 2024 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-24-021730 | Feb 13, 2024 | — |
| SC 13G/A | — | 0001086364-24-005056 | Jan 29, 2024 | — |
| S-8 | S-8 | 0001193125-24-013722 | Jan 24, 2024 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-24-001993 | Jan 22, 2024 | Jan 18, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-24-001995 | Jan 22, 2024 | Jan 18, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-24-001999 | Jan 22, 2024 | Jan 18, 2024 |
| 8-K | 8-K | 0001193125-24-010177 | Jan 18, 2024 | — |